LRRK2-IN-3 (化合物 24) 是一种有效，选择性，具有口服活性和可透过血脑屏障的LRRK2抑制剂，在 hPBMCs 中的IC50值为 0.6 nM。LRRK2-IN-3 可用于帕金森氏病的研究。

LRRK2-IN-3 (compoubd 24) is a potent, selective, orally active and brain-penetrant inhibitor LRRK2, with IC 50 of 2.6 nM in human PBMCs. LRRK2-IN-3 can be used for the research of Parkinson's disease [1].

2641054-60-4

C25H29ClF2N6O2

518.99

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years